Free Trial

Maravai LifeSciences (MRVI) Earnings Date, Estimates & Call Transcripts

$9.16
+0.65 (+7.64%)
(As of 07/26/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 7
After Market Closes
Confirmed
Actual EPS
(May. 8)
-$0.11 Missed By -$0.05
Consensus EPS
(May. 8)
-$0.06
Skip Charts & View Estimated and Actual Earnings Data

MRVI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRVI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Maravai LifeSciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.15) EPS
Next Year EPS Consensus Estimate: ($0.13) EPS

MRVI Earnings Date and Information

Maravai LifeSciences last issued its quarterly earnings results on May 8th, 2024. The reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.05. The company earned $64.18 million during the quarter, compared to analyst estimates of $60.84 million. Maravai LifeSciences has generated ($0.99) earnings per share over the last year (($0.99) diluted earnings per share). Earnings for Maravai LifeSciences are expected to grow in the coming year, from ($0.15) to ($0.13) per share. Maravai LifeSciences has confirmed that its next quarterly earnings report will be published on Wednesday, August 7th, 2024. Maravai LifeSciences will be holding an earnings conference call on Wednesday, August 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call..

Maravai LifeSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/7/2024
(Confirmed)
-------  
5/8/2024Q1 2024($0.06)($0.11)($0.05)($0.13)$60.84 million$64.18 million
2/22/2024Q4 2023($0.04)($0.05)($0.01)$0.70$62.99 million$74.14 million
11/7/2023Q3 2023($0.03)($0.02)+$0.01$0.01$75.23 million$66.87 million
8/7/2023Q2 2023($0.02)($0.06)($0.04)($0.07)$70.30 million$68.91 million
5/8/2023Q1 2023$0.04$0.03($0.01)$0.06$79.72 million$79.03 million    
2/22/2023Q4 2022$0.34$0.35+$0.01$0.42$204.95 million$204.70 million    
11/2/2022Q3 2022$0.32$0.37+$0.05$0.40$193.83 million$191.26 million
8/4/2022Q2 2022$0.45$0.54+$0.09$0.55$234.91 million$242.73 million
5/5/2022Q1 2022$0.43$0.54+$0.11$0.58$232.29 million$244.30 million    
2/23/2022Q4 2021$0.38$0.45+$0.07$0.48$208.09 million$228.44 million    
11/10/2021Q3 2021$0.35$0.44+$0.09$0.65$199.68 million$204.81 million    
8/10/2021Q2 2021$0.32$0.44+$0.12$0.44$195.49 million$217.80 million    
5/10/2021Q1 2021$0.19$0.26+$0.07$0.28$135.36 million$148.20 million  
3/1/2021Q4 2020$0.11$0.13+$0.02$0.13$87.48 million$98.35 million  

Maravai LifeSciences Earnings - Frequently Asked Questions

When is Maravai LifeSciences's earnings date?

Maravai LifeSciences has confirmed that its next quarterly earnings data will be published on Wednesday, August 7th, 2024. Learn more on MRVI's earnings history.

What guidance has Maravai LifeSciences issued on next quarter's earnings?

Maravai LifeSciences issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company issued revenue guidance of $265.0 million-$285.0 million, compared to the consensus revenue estimate of $271.8 million.

Did Maravai LifeSciences beat their earnings estimates last quarter?

In the previous quarter, Maravai LifeSciences (NASDAQ:MRVI) missed the analysts' consensus estimate of ($0.06) by $0.05 with a reported earnings per share (EPS) of ($0.11). Learn more on analysts' earnings estimate vs. MRVI's actual earnings.

How much revenue does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded annual revenue of $288.95 million.

How much profit does Maravai LifeSciences generate each year?

Maravai LifeSciences (NASDAQ:MRVI) has a recorded net income of -$119.03 million. MRVI has generated -$0.99 earnings per share over the last four quarters.

What is Maravai LifeSciences's EPS forecast for next year?

Maravai LifeSciences's earnings are expected to grow from ($0.15) per share to ($0.13) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MRVI) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners